ArticleNeurological research and practice2025

Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteria.

Duc Chu Dieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.